Search Results for "Sinus Bone Destruction"
Original Source: Unilateral maxillary sinusitis : A cavernous haemangioma with bone destruction.
Haemangioma originating in the paranasal sinuses are a rare entity. In the case of unilateral sinusitis the differential diagnosis should include tumors. The following case of a 30-year-old female patient with a therapy-resistant sinusitis showed bone destruction and a maxillary shadow on computed tomography. The histological exam resulted in a cavernous haemangioma.
Matching Channels
Nose and Paranasal Sinus Disorders
Sinus node dysfunction refers to a number of conditions producing physiologically inappropriate atrial rates. Symptoms may be minimal or include weakness, palpitations, and syncope. Diagnosis is by...
Matching News
Maxillent Ltd. is developing an alternative to invasive sinus lift procedures for augmenting bone prior to placing dental implants. Its iRaise is a closed sinus-lift implant system that not only augme...
Bone Health Improved Even by a Little Physical Activity
As little as 2 hours a week of walking or other exercise may reduce bone destruction and increase bone formation in premenopausal women. Medscape Medical News
Bone: An alternative pathway for bone destruction in inflammatory arthritis?
Study compares transcrestal techniques for maxillary sinus floor elevation
For a successful dental implant, the first step for some patients is reconstructive surgery of the jaw. A bone graft to augment the upper jaw can now be achieved by several methods. To assess these me...
Lindsay B. Eastman, DDS, MS, PA, knows that not everyone has the structure to support dental implants. However, patients with insufficient amounts of bone in the upper jaw may be good candidates for...
Denosumab reduces burden of giant-cell tumor of the bone, study suggests
Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased...
Xgeva Reduces Giant-cell Tumor of the Bone
Xgeva® (denosumab) significantly reduced or eliminated tumor giant cells in patients with giant-cell tumor of the bone and also increased new bone formation, according to the results of a phase II st...
BioHorizons introduces new mineralized cancellous bone allograft
BioHorizons has introduced a new mineralized cancellous bone allograft, MinerOss Cancellous, for periodontal defects, extraction sockets, grafting for implant placement, and ridge and sinus augmentati...
Matching PubMed Articles
OBJECTIVES: This study aims to evaluate the effect of adding bone substitute materials (BSM) to particulated autogenous bone (PAB) on the volume fraction (Vf) of newly formed bone after maxillary sinu...
Simple and safe exposure of the sigmoid sinus with presigmoid approaches.
Although entire exposure of the sigmoid sinus has been recognized as a complicated procedure in presigmoid approaches, we developed a new technique to expose the sigmoid sinus quite safely and simply...
The reconstruction of edentulous patients with adequate bone volume and density by the use of bone graft and, subsequently, the placement of dental implants has become a viable treatment option with h...
BACKGROUND: Implant dentistry in the posterior maxilla often requires bone augmentation. The gold standard, autogenous bone graft, requires additional surgery with associated morbidity, while bone bio...
OBJECTIVE: The present study investigated the efficacy of a biphasic calcium phosphate as a bone grafting material for maxillary sinus augmentation in humans. MATERIALS AND METHODS: Half of the thirty...
